Abstract:Background: Despite successful ART in people living with HIV infection (PLHIV) they experience increased morbidity and mortality compared with HIV-negative controls. A dominant paradigm is that gut-associated lymphatic tissue (GALT) destruction at the time of primary HIV infection leads to loss of gut integrity, pathological microbial translocation across the compromised gastrointestinal barrier and, consequently, systemic inflammation. We aimed to identify and measure specific changes in the gastrointestinal barrier that might allow bacterial translocation, and their persistence despite initiation of antiretroviral therapy (ART). Method: We conducted a cross-sectional study of the gastrointestinal (GIT) barrier in PLHIV and HIV-uninfected controls (HUC). The GIT barrier was assessed as follows: in vivo mucosal imaging using confocal endomicroscopy (CEM); the immunophenotype of GIT and circulating lymphocytes; the gut microbiome; and plasma inflammation markers Tumour Necrosis Factor-α (TNF-α) and Interleukin-6 (IL-6); and the microbial translocation marker sCD14. Results: A cohort of PLHIV who initiated ART early, during primary HIV infection (PHI), n=5), and late (chronic HIV infection (CHI), n=7) infection were evaluated for the differential effects of the stage of ART initiation on the GIT barrier compared with HUC (n=6). We observed a significant decrease in the CD4 T-cell count of CHI patients in the left colon (p=0.03) and a trend to a decrease in the terminal ileum (p=0.13). We did not find evidence of increased epithelial permeability by CEM. No significant differences were found in microbial translocation or inflammatory markers in plasma. In gut biopsies, CD8 T-cells, including resident intraepithelial CD103+ cells, did not show any significant elevation of activation in PLHIV, compared to HUC. The majority of residual circulating activated CD38+HLA-DR+ CD8 T-cells did not exhibit gut-homing integrins α4ß7, suggesting that they did not originate in GALT. A significant reduction in the evenness of species distribution in the microbiome of CHI subjects (p=0.016) was observed, with significantly higher relative abundance of the genus Spirochaeta in PHI subjects (p=0.042). Conclusion: These data suggest that substantial, non-specific increases in epithelial permeability may not be the most important mechanism of HIV-associated immune activation in well-controlled HIV-positive patients on antiretroviral therapy. Changes in gut microbiota warrant further study.

Tu1289 SCNN1B is a Novel Tumor Suppressor Gene Through Inducing Ubiquitin-Mediated Degradation of GRP78 and is a Potential Prognostic Biomarker in GC

Increased Microbial Translocation is a Prognostic Biomarker of Different Immune Responses to ART in People Living with HIV

Distribution of H.pylori Antigens in Gastric Mucosa and Its Significance.

Prognostic Effects of the Gastric Mucosal Microbiota in Gastric Cancer

High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.

Non-parallel coevolution of sender and receiver in the acoustic communication system of treefrogs

Prediction of progression of chronic atrophic gastritis with Helicobacter pylori and poor prognosis of gastric cancer by CYP3A4

Correlation of Oral Microbiota with Different Immune Responses to Antiretroviral Therapy in People Living with HIV

The Expression of Heat Shock Protein 70/90 in Patients with Atrophic Gastritis or Gastric Cancer and Its Significance

Coding RNA expression profile and transcription factor analysis of H.pylori-associated chronic atrophic gastritis

Uveitis in the southeastern United States.

Alterations of Gastric Mucosal Microbiota Across Different Stomach Microhabitats in a Cohort of 276 Patients with Gastric Cancer

Helicobacter Pylori Antibodies in Relation to Precancerous Gastric Lesions in a High-Risk Chinese Population.

The Analysis for Human Immunodeficiency Virus Infection in Gastric Mucosa from Acquired Immune Deficiency Syndrome Patients

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection

Health-related quality of life after maxillectomy: obturator rehabilitation compared with flap reconstruction.

Circulating (1 → 3)-Β-d-glucan As an Immune Activation Marker Decreased after ART in People Living with HIV.

GP73 is a potential marker for evaluating AIDS progression and antiretroviral therapy efficacy

Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

Chaperone function of two small heat shock proteins from maize.

[Serological Assessment of Helicobacter Pylori-Specific Antibodies and Their Association with Gastric Lesions in a High-Risk Population].